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ABSTRACT
Generation of the polyadenylated 3 end of an mRNA requires an endonucleolytic cleavage followed by synthesis of the poly(A)
tail. Despite the seeming simplicity of the reaction, more than a dozen polypeptides are required, and nearly all appear to be
necessary for the cleavage reaction. Because of this complexity, the identity of the endonuclease has remained a mystery. Here
we present evidence that a component of the cleavage-polyadenylation specificity factor CPSF-73 is the long-sought endo-
nuclease. We first show, using site-specific labeling and UV-cross-linking, that a protein with properties of CPSF-73 is one of
only two polypeptides in HeLa nuclear extract to contact the cleavage site in an AAUAAA-dependent manner. The recent
identification of CPSF-73 as a possible member of the metallo--lactamase family of Zn2+-dependent hydrolytic enzymes
suggests that this contact may identify CPSF-73 as the nuclease. Supporting the significance of the putative hydrolytic lactamase
domain in CPSF-73, we show that mutation of key residues predicted to be required for activity in the yeast CPSF-73 homolog
result in lethality. Furthermore, in contrast to long held belief, but consistent with properties of metallo--lactamases, we show
that 3 cleavage is metal-dependent, likely reflecting a requirement for tightly protein-bound Zn2+. Taken together, the available
data provide strong evidence that CPSF-73 is the 3 processing endonuclease.
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INTRODUCTION
All mRNA precursors in eukaryotic cells must undergo 3
processing in the nucleus before their transport to the cy-
toplasm. This almost always entails a two-step reaction in
which the pre-mRNA first undergoes site-specific endonu-
cleolytic cleavage to generate the mRNA 3 end, which then
serves as a primer for synthesis of a poly(A) tail. Although
both reactions, which are coupled in vivo but can be sepa-
rated in vitro, are in principle quite simple, in fact, they
require a complex set of protein factors (for review, see
Colgan and Manley 1997; Zhao et al. 1999a; Edmonds
2002). These include, in mammals, cleavage-polyadenyla-
tion specificity factor (CPSF), which recognizes the nearly
ubiquitous AAUAAA signal; cleavage stimulatory factor
(CstF), which interacts with a less-conserved G/U-rich se-
quence situated downstream of the cleavage site; cleavage
factors I and II (CFI and CFII), and finally poly(A) poly-
merase (PAP). Remarkably, all these factors, including in
most cases PAP, are necessary for the cleavage reaction. In
addition, the carboxy-terminal domain of the RNA poly-
merase II (RNAP II) largest subunit (CTD) was also found
to be required for efficient pre-mRNA cleavage (for review,
see Hirose and Manley 2000; Bentley 2002; Proudfoot and
O’Sullivan 2002). As all of these factors, except PAP, are
multisubunit, more than a dozen polypeptides (not includ-
ing RNAP II) are required for the 3 cleavage reaction.
Although the mRNA signals for 3 end formation in yeast
are distinct from these in mammals, many of the mamma-
lian factors have yeast counterparts, and the polyadenyla-
tion machinery in yeast is at least as complex as its mam-
malian counterpart (Zhao et al. 1999a).
The current compilation of cleavage/polyadenylation fac-
tors is the result of years of biochemical fractionation and
analysis, and more recently genetic studies in yeast. Al-
though the list is believed to be essentially complete, a more
confident assessment of this awaits total reconstitution in
vitro. Although specific functions for many of the polypep-
tides are known, for example, the key RNA-binding sub-
units appear to be the CPSF subunits CPSF-160 and CPSF-
30 and the CstF-64 subunit of CstF, the precise roles of
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many of the proteins, such as CPSF-73, CPSF-100, and the
various subunits of CFI and CFII, remain largely undefined.
Most important, whereas 3 processing has been known to
entail an endonucleolytic cleavage for nearly a quarter cen-
tury, the identity of the actual endoribonuclease remains
unknown (for discussion, see Shatkin and Manley 2000).
After so many years of study one might ask what, in a
process whose activity is divided among so many required
subunits, will proof of an endonucleolytic role actually en-
tail? Might one expect to find an individual subunit, or
small group of subunits, that will cleave a pre-mRNA sub-
strate in vitro? If so, would such cleavage be sequence-
specific, or result in more random degradation of a test
RNA substrate? To our knowledge, no experiments, using
either fractionated factors or recombinant subunits, have
revealed a specific factor, let alone single polypeptide, with
nuclease activity unequivocally ascribable to it. We describe
here our efforts to solve this problem. This involved first
identification of components of the precleavage complex
that contact directly the actual cleavage site of a pre-mRNA
substrate. Accordingly, we prepared a substrate RNA whose
scissile phosphate carried the only radioactive label in the
molecule, and characterized proteins that contact the cleav-
age site by UV cross-linking. We found that this substrate
cross-links in an AAUAAA-dependent manner to only two
proteins in the HeLa nuclear extract, CstF-64, and another
protein of ∼75–80 kD. Additional genetic and biochemical
experiments, together with recent bioinformatic studies,
lead us to conclude that this protein corresponds to CPSF-
73, and that CPSF-73 is likely to be the long-sought 3
processing endoribonuclease.
RESULTS AND DISCUSSION
In an effort to identify the 3 pre-mRNA processing endo-
nuclease, we first set out to identify proteins that contact the
scissile phosphate at the cleavage site in a poly(A) signal
(i.e., AAUAAA)-dependent manner. For this, we prepared
wild-type (AAUAAA) and mutant (AAAAAA) derivatives of
the SV40 late polyadenylation substrate containing a single,
site-specific 32P label at this phosphate for utilization in
UV-cross-linking assays with HeLa cell nuclear extract (NE;
see Fig. 1A and Materials and Methods). The site-specifi-
cally labeled SV40 late poly(A) substrate (SSL) extended
30-nucleotides on the 3 side of the cleavage site so as to
include the G/U-rich (CstF-binding) downstream element
(e.g., Beyer et al. 1997; Takagaki and Manley 1997). A uni-
formly labeled version of this substrate, prepared by in vitro
FIGURE 1. Two Hela cell proteins photo cross-link to the SV40 L poly(A) site in vitro. (A) Diagram of the two SV40L pre-mRNA substrates used
in this study. The asterisk in the site-specifically labeled (SSL) substrate denotes the natural SV40L cleavage site, the site-specific 32P phosphate
label, and the site of ligation between the 179-nucleotide upstream in vitro transcribed piece and the 30-nt downstream chemically synthesized
piece. The uniformly labeled substrate (UL) was made by in vitro transcription of the DraI-digested pG3SVL-A plasmid using either [-32P]GTP
or UTP. The underlined U was changed to A in the mutated poly(A) substrate (mutant). (B) UV cross-linking of both proteins is AAUAAA-
dependent. Either the mutant or wild-type substrates, UL or SSL, were irradiated in nuclear extract, digested with RNAse A then immunopre-
cipitated with the anti-Cstf-64 monoclonal antibody 3A7. (CIP) calf intestinal alkaline phosphatase treatment just before IP; (H.D.) heat-
denaturation just before IP. Input, I, either 7.5% or 10% of one 10-µL reaction. Prestained protein markers (M) are indicated with dashes. (C)
As in B except: wild-type SV40L substrates and immunoprecipitated with the indicated antibody.
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transcription, oligonucleotide-directed RNase H digestion,
and gel purification, was processed in NE as efficiently as
the standard, uniformly labeled cleavage substrate (UL),
also diagrammed in Figure 1A (data not shown). To test the
poly(A) signal dependence of cross-linking we made mu-
tant versions of both substrates in which the U (underlined
here and in Fig. 1A) of the CPSF recognition site AAUAAA
was changed to A. In addition, all four substrates, SSL and
UL, each either wild type or mutated, contain only natural
RNA nucleotides. Although we considered use of non-natu-
ral, photo-cross-linkable chemical functional groups to in-
crease the cross-linking efficiency, we instead used the natu-
ral RNA to avoid any perturbation of the precleavage com-
plex. Thus, our SSL substrates were composed of only
natural RNA nucleotides, and included the appropriate cis-
acting elements needed to elicit efficient in vitro processing.
The results of a representative UV cross-linking experi-
ment are shown in Figure 1B. The first four lanes charac-
terize the interaction between the uniformly labeled wild-
type SV40 cleavage substrate (UL) and HeLa nuclear pro-
teins. As observed previously (e.g., Takagaki et al. 1990),
this identified an AAUAAA-dependent ∼65-kD protein that
was confirmed to be the CstF-64 component of CstF by
immunoprecipitation with the anti-CstF-64 monoclonal
antibody (mAb) 3A7 (Fig. 1B, lane 4). The cross-linking
reactions using the site-specifically labeled substrates
showed a group of poorly resolved bands and very little
AAUAAA dependence (Fig. 1B, lanes 5,7). However, when
the crude reaction was immunoprecipitated using the 3A7
mAb, the difference was striking: The wild-type AAUAAA-
containing RNA but not the mt RNA was observed to cross-
link to two proteins that were precipitated by the anti-CstF-
64 mAb (Fig. 1B, lane 8). Somewhat surprisingly, one comi-
grated with the CstF-64 cross-linked to the uniformly
labeled RNA substrate. Treatment of the reaction mixture
with phosphatase before immunoprecipitation (Fig. 1B,
lane 9) demonstrated that the more slowly migrating band
was not a phosphorylated form of CstF-64, but rather a
protein that was coimmunoprecipitated by the 3A7 anti-
body. This was confirmed by heating (4 min, 100°C) the
reaction mixture before immunoprecipitation to disrupt
noncovalently bound complexes, and this eliminated pre-
cipitation of the low mobility species but not CstF-64 (Fig.
1B, lane 10). In this and other experiments (see below) we
found that the 3A7 antibody was unusual in that it recog-
nized its epitope even after vigorous heat denaturation of
the extract. Thus, the SSL substrate transferred its labeled
phosphate to two proteins in an AAUAAA-dependent man-
ner, and one of these proteins was identified as CstF-64.
This was unexpected because CstF-64 is known to bind
directly to the downstream G/U-rich element. The interac-
tion with the cleavage site is intriguing, but additional stud-
ies will be required to determine its significance. On the
basis of the known properties of CstF-64 and experiments
described below, CstF-64 is unlikely to be the endonuclease.
The more slowly migrating protein had an apparent mo-
lecular mass in the range of roughly 75–80 kD, and seemed
to be a better candidate.
The data in Figure 1B showed that two proteins labeled in
the UV cross-linking were precipitated by the anti-CstF-64
antibody. But this experiment could not determine either
the identity of the higher molecular weight (MW) protein
or whether it bound CstF-64 directly or through the me-
diation of other, unlabeled proteins also contained in a
post-cross-linking complex. To investigate this further, we
repeated the experiment with antibodies to other known
cleavage factors, including CstF-77, CPSF-100, PAP, and
the RNAP II CTD. The CPSF-100 antibody used is known
to cross-react with CPSF-73 by virtue of the sequence simi-
larity between these two CPSF subunits (e.g., Takagaki and
Manley 2000). The results using some of these antibodies
are shown in Figure 1C. Both the anti-CstF-77 (Fig. 1C, lane
6) and the anti-CPSF-100 (Fig. 1C, lane 8) antibodies pre-
cipitated the same two labeled proteins that were precipi-
tated by the anti-CstF-64 antibody (Fig. 1C, lane 4). This
indicated that CstF-77, CPSF-73, or CPSF-100 was also pres-
ent in the post-cross-linking 3-processing complex. How-
ever, neither the anti-CstF-77 (Fig. 1C, lane 7) nor the
anti-CPSF-100 (Fig. 1C, lane 9) antibody precipitated the
labeled proteins after heat denaturation, leading to the pos-
sibility that neither labeled band corresponds to the anti-
gens of these antibodies, or that the epitope was destroyed
by boiling. We tested this in a separate experiment using
Western blotting of heat denatured, immunoprecipitated
NE. These two antibodies, in contrast to the 3A7 mAb, were
both unable to immunoprecipitate their respective antigens
after the extract had been boiled (not shown). Therefore, we
were unable to determine whether the antibodies to CPSF-
100/73 and CstF-77 precipitated the slower migrating spe-
cies directly or indirectly, and hence could not identify that
protein conclusively by these experiments. The antibodies
to RNAP II CTD and PAP did not precipitate any proteins
labeled in the cross-linking reaction (not shown), and these
proteins were therefore considered unlikely to be part of the
post-cross-linking processing complex.
Among the known 3 cleavage factors, only two have
molecular weights that make them candidates for the uni-
dentified protein detected in the cross-linking reactions.
Both CPSF-73 (MW 77,486) and CstF-77 (MW 82,921) fall
within this range. Unfortunately, these experiments, as well
as related ones with several additional antibodies (not
shown), were unable to conclusively distinguish between
these two polypeptides. However, we believe that CPSF-73
is more likely to be the unidentified protein, and in fact the
3 endonuclease, for the following three reasons: First, the
CPSF-73 sequence is the most highly conserved among all
the eukaryotic 3 processing factors (see below), a trait that
would be expected for the protein directly responsible for
catalysis. Second, cytoplasmic CPSF specifically lacks CPSF-
73 (Dickson et al. 1999; Mendez et al. 2000). Although
CPSF-73 as the mRNA 3 endonuclease
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cytoplasmic CPSF retains the ability of the nuclear CPSF to
direct polyadenylation by interaction with PAP and the
mRNA, it has not been implicated in any RNA cleavage
activity. Indeed, the presence of the endonuclease could be
deleterious, as it could conceivably cleave the short poly(A)
tail from cytoplasmic mRNAs that are in fact substrates for
poly(A) extension. The third and perhaps most persuasive
line of reasoning implicating CPSF-73 as
the 3 nuclease is the identification of
CPSF-73 as a member of the metallo--
lactamase fold superfamily; a diverse
group of proteins many of which use zinc
as a cofactor in their role as hydrolytic
enzymes such as esterases and lactamases
(Aravind 1999). More recently, CPSF-73
has been classified as a founding member
of the -CASP subfamily of metallo--
lactamases (Callebaut et al. 2002). Pro-
teins of this subgroup have been sug-
gested to participate in nucleic acid me-
tabolism, and significantly include the
DNA endonuclease Artemis (Ma et al.
2002). CPSF-100, being related to CPSF-
73, has also been classified as a -CASP
protein but, based on alterations in the
conserved -CASP sequence motifs, is
assumed not to be capable of any hydro-
lytic catalysis (Callebaut et al. 2002).
This is consistent with our inability to
detect CPSF-100 in contact with the
cleavage site. These findings not only
point to CPSF-73 as a potential hydro-
lytic enzyme, and thus a candidate for the
3 endonuclease, but also lead to the pre-
diction that a group of specific residues
in CPSF-73 are zinc- or other divalent
metal-chelating residues, and that these
residues may play an essential, catalytic
role in hydrolysis of the pre-mRNA.
To test this prediction, we studied the
yeast homolog of CPSF-73, Ysh1p. Ysh1/
Brr5 was independently cloned and char-
acterized by Chanfreau et al. (1996) and
Jenny et al. (1996) and shown to be es-
sential for cell viability and for 3 end
processing both in vivo and in vitro. The
Ysh1p sequence shows similarity to both
the 100-kD and 73-kD subunits of mam-
malian CPSF, being 23% identical over
the entire length of CPSF-100 and a strik-
ing 53% identical in the first 500 amino
acids to CPSF-73 (Chanfreau et al. 1996;
Jenny et al. 1996).
Typical metallo--lactamase fold pro-
teins contain five highly conserved se-
quence motifs (1–5) that participate in zinc coordination
and catalysis. The -CASP subfamily, however, is distinct,
containing in place of motif 5 the -CASP domain, which
in turn contains three conserved motifs, A–C (Fig. 2A; Cal-
lebaut et al. 2002). Thus, -CASP proteins are defined by
the presence of seven sequence motifs, all of which include
an acidic or histidine residue known or predicted to par-
FIGURE 2. Mutation of conserved residues in the metallo--lactamase and -CASP con-
sensus motifs of the yeast CPSF-73 homolog Ysh1p causes lethality. (A) Abbreviated sequence
alignment between scYsh1p, hCPSF-73, and hArtemis showing the -lactamase motifs 1–4
and -CASP motifs A, B, and C (adapted from Callebaut et al. 2002). Residues substituted
individually in the plasmid shuffle assay are shown directly below the native Ysh1p residue. (B)
Plasmid shuffling was used to test whether E209 of the -CASP consensus in Ysh1p is essential
for cell viability. Chromosomal YSH1 was disrupted with HIS3 and replaced by YSH1 on a
URA3 plasmid. Cells were transformed with a LEU plasmid bearing wild-type YSH1, ysh1-209,
or no insert (vector). Individual colonies were isolated and streaked on plates with or without
5-FOA. (Inset) Western blot of cell extracts comparing flu epitope-tagged wild-type and
mutant ysh1p. (C) Plasmid shuffling was done as in B with four additional ysh1 mutants that
alter the residues indicated (see text).
Ryan et al.
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ticipate in metal binding and hydrolysis. For example, motif
A contains an acidic residue that has been shown to be
required for activity of the DNA endonuclease Artemis
(D165; Ma et al. 2002). To investigate whether the corre-
sponding residue, E209, is essential for Ysh1p function, we
used site-directed mutagenesis and a plasmid-shuffling
procedure. We created a strain with a chromosomal dele-
tion of YSH1 (ysh1HIS3) that contained wild-type YSH1
on a plasmid with a URA3–selective marker and, in addi-
tion, either wild-type YSH1, the ysh1–209 mutant (E209Q)
or no insert on a plasmid containing a LEU2-selective
marker. The plasmid with the URA3marker was then coun-
terselected on medium containing 5-fluoro-orotic acid (5-
FOA). Wild-type YSH1, but not ysh1–209 or vector alone,
complemented the chromosomal YSH1
deletion (Fig. 2B). Western blots revealed
that flu epitope-tagged wild-type and
mutant proteins accumulated to compa-
rable levels (Fig. 2B). To extend this re-
sult, we analyzed in an identical way four
additional mutations that each alter a
residue predicted to be essential for ac-
tivity, one in -CASP motif B and the
others in motifs 1, 2, and 4 (see Fig. 2A).
Strikingly, all four resulted in lethality
upon loss of YSH1 (Fig. 2C). These re-
sults strongly suggest that the putative
metallo--lactamase/-CASP domain
exists in Ysh1p and is essential for activ-
ity. This in turn supports the hypothesis
that CPSF-73/Ysh1p is the 3 processing
endonuclease.
It has long been known that dialysis of
NE leads to partial loss of 3 processing
activity (e.g., Wahle and Keller 1994). It
has likewise long been assumed that the
3 endonuclease is metal independent be-
cause the reaction proceeds in vitro in the
presence of high concentrations of EDTA
(e.g., Hirose and Manley 1997 and refer-
ences therein). But this seemed inconsis-
tent with the presence of a functional
metallo--lactamase fold in CPSF-73,
which is supported by the genetic analy-
sis described above. One possible expla-
nation for the dialysis-dependent reduc-
tion of NE cleavage activity is that a low
molecular weight cofactor, such as zinc,
is partially lost during dialysis. Although
physiological zinc concentrations are
very low (Outten and O’Halloran 2001)
and protein-bound zinc is tightly held,
perhaps explaining the resistance of
cleavage to EDTA, it is conceivable that
during dialysis in the presence of low lev-
els of EDTA CPSF-73 loses some of its zinc, thereby inac-
tivating a fraction of the protein. In fact, some metallo--
lactamases bind two zinc atoms, one tightly and one loosely,
with both needed for efficient catalysis but one sufficient for
minimal activity (Wang et al. 1999), and CPSF-73 could fall
into this category.
We first tested whether ZnCl2 is able to restore cleavage
activity lost during dialysis of NE. Figure 3A, lane 1, shows
a cleavage reaction using the SV40 late substrate, without
dialysis of the extract, and in the presence of a typically high
concentration (2 mM) of EDTA. This EDTA concentration
also prevents subsequent polyadenylation of the 5 cleavage
product. Removal of all the EDTA but that contributed by
the nuclear extraction buffer led to cleavage as well as poly-
FIGURE 3. 3 Cleavage is divalent cation-dependent, and zinc supports both cleavage and
polyadenylation in vitro. (A) ZnCl2 partially restores cleavage activity lost during nuclear
extract dialysis. (Lane 1) Cleavage of uniformly labeled SV40L pre-mRNA in the presence of
2 mM EDTA. Cleavage (lane 3) or cleavage and polyadenylation (lane 2) in the presence of
added ZnCl2. (Lane 4) Loss of cleavage activity upon dialysis (cf. lane 1). (Lanes 5,6) Partial
restoration of cleavage activity by addition of increasing zinc concentration. (Lane 7) ZnCl2
supports poly(A) addition in the absence of exogenous MgCl2. (B) EDTA at high concentra-
tions and the zinc-specific chelators TPEN and OP at low concentrations inhibit cleavage. In
addition to the chelators listed above the gel, each sample contained 2 mM EDTA. (C)
Inhibition of cleavage by EDTA and TPEN is concentration dependent.
CPSF-73 as the mRNA 3 endonuclease
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adenylation, the latter likely supported by the MgCl2 con-
tributed by the buffer (Fig. 3A, lane 2). Including 2 mM
2-dATP in the reaction (Fig. 3A, lane 3) terminated this
polyadenylation activity. Figure 3A, lane 4, shows the extent
to which cleavage activity was reduced by dialysis of the
extract against a buffer containing 0.2 mM EDTA. Most
significantly, Figure 3A, lanes 5 and 6, show that partial
restoration of activity was achieved when increasing
amounts of ZnCl2 were added. Withholding 2-dATP from
the reaction (Fig. 3A, lane 7) revealed that ZnCl2 could also
support polyadenylation, suggesting that the poly(A) addi-
tion observed in Figure 3A, lane 2, may have been sup-
ported by either ZnCl2 or the residual MgCl2 from the
extraction buffer. In any event, this experiment demon-
strated that ZnCl2 stimulated 3 cleavage in a concentra-
tion-dependent manner in a divalent cation-deficient ex-
tract.
We also approached the question of possible zinc-depen-
dent 3 cleavage by adding either a higher concentration of
EDTA or relatively low concentrations of two different zinc-
specific chelators to in vitro cleavage reactions using the
nondialyzed NE (Fig. 3B). Increasing the EDTA concentra-
tion from 2 to 12 mM significantly inhibited in vitro cleav-
age (Fig. 3B, lanes 3,4), consistent with our previous results
showing that cleavage was resistant to 4 mM EDTA and
modestly inhibited by 8 mM (Hirose and Manley 1997).
Strikingly, the zinc-specific chelators TPEN (N,N,N,N-tet-
rakis(2-pyridylmethyl)ethylenediamine) and OP (ortho-
phenanthroline; Siemann et al. 2002) each partially inhib-
ited cleavage at 100 µM, far below the EDTA concentrations
required for inhibition. Figure 3C extends these results,
showing that inhibition by TPEN was concentration depen-
dent and ∼50-fold more effective than EDTA. (Note that the
NE used in Fig. 3, B and C, was the same, although both
cleavage efficiency and resistance to EDTA and TPEN were
reduced in the experiment shown in Fig. 3C. This reflects
time-dependent loss of activity that occurs with nondia-
lyzed extracts, even when stored at −80°C [K. Ryan and F.
Kleiman, unpubl. data]. Although the basis for this is un-
known, it is intriguing that decreased cleavage efficiency
and increased sensitivity to chelators are correlated.)
The data in Figure 3 show that the 3 pre-mRNA cleav-
age, in contrast to long-standing belief, is in fact a metal-
dependent process. Because cleavage activity could be par-
tially restored to a dialyzed extract by adding back ZnCl2,
and because cleavage in the nondialyzed extract was inhib-
ited by low concentrations of zinc-specific chelators, our
data also suggest that zinc is the metal cofactor needed for
cleavage. This is consistent with the properties of the
metallo--lactamase domain in CPSF-73. However, it is
also possible that the zinc dependence reflects the need for
zinc by CPSF-30, a CPSF subunit known to bind RNA in
vitro and to have five zinc fingers and one zinc knuckle
(Barabino et al. 1997). Indeed, it has been suggested that the
Drosophila homolog of CPSF-30 possesses endonuclease ac-
tivity (Bai and Tolias 1996). However, several observations
suggest that CPSF-30 is unlikely to be the 3 endonuclease.
First, it has no motifs or domains consistent with nuclease
activity. Second, our cross-linking experiments failed to
provide evidence that CPSF-30 contacts the pre-mRNA in
the vicinity of the cleavage site. Finally, reconstitution ex-
periments with both yeast (Zhao et al. 1999b) and mam-
malian (Murthy and Manley 1992) factors provided evi-
dence that CPSF-30 can be dispensable for cleavage in vitro.
Our data together with other findings strongly suggest
that CPSF-73 is the long sought 3 endonuclease. Although
formal proof of this would require the demonstration that
purified CPSF-73 display endonuclease activity in vitro, this
may well be impossible. Technically, recombinant bacteri-
ally expressed CPSF-73 is exceptionally insoluble (data not
shown) and therefore difficult to work with. Perhaps more
significant, both biochemical and genetic experiments sug-
gest that a dozen or more polypeptides are required for
authentic 3 cleavage, in vitro as well as in vivo. It thus may
be that CPSF-73 will display activity only in a multiprotein
complex, which would in turn make it impossible from
such experiments to state conclusively that CPSF-73 is the
actual nuclease. Nevertheless, the available evidence
strongly suggests that CPSF-73 is the pre-mRNA 3 endo-
nuclease. Figure 4 depicts a revised view of the core poly-
adenylation machinery that incorporates the positioning of
CPSF-73 at the cleavage site.
MATERIALS AND METHODS
Extracts and antibodies
Nuclear extract was prepared from HeLa cells as described by
Dignam et al. (1983) with minor modifications (Takagaki et al.
1988), and either dialysed in buffer D (4°C, 10 h in 20% glycerol,
20 mM Na-HEPES, pH 7.9, 0.5 mM DTT, 50 mM ammonium
sulfate, 0.2 mM EDTA, and 0.2 mM PMSF) or left in the extrac-
tion buffer without dialysis (15% glycerol, 14 mM Na-HEPES, pH
FIGURE 4. CPSF-73 as the 3 processing nuclease. The core polyade-
nylation machinery (e.g., RNAP II is not included) is illustrated as it
would assemble in a precleavage complex on an mRNA precursor,
with CPSF-73 at the site of cleavage. The AAAUAA and GU-rich signal
sequences are indicated, and the arrow denotes the cleavage site. The
protein–protein and protein–RNA interactions depicted are consistent
with available data. See text for details of protein factors.
Ryan et al.
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7.9, 0.5 mM DTT, 0.25 M NaCl, 2.5 mM KCl, 1.38 mM MgCl2,
0.12 mM EDTA). Total nuclear extract protein concentration as
measured by the Bio-Rad Protein assay (Bio-Rad) ranged from 4.4
to 4.9 mg/mL. Immunoprecipitation (IP) buffer IP2 was 50 mM
Tris-HCl (pH 7.6), 50 mM NaCl, and included 0.1 mg/mL BSA
and 0.1% NP-40 unless otherwise indicated. CstF-77 and CPSF-73
rabbit polyclonal antibodies were kindly provided by D. Bentley
(Univ. of Colorado, Denver). The PAP rabbit polyclonal antibody
was a gift of V. Vethantham (Columbia Univ., New York). The
CTD antibody 8WG16 was purchased from Covance Research
Products.
Preparation of cross-linking/processing substrates
The site specifically scissile phosphate labeled SV40L substrate
(SSL) was made from two RNA fragments that were ligated using
the standard RNA ligation procedure (Moore and Sharp 1993).
To produce the capped upstream piece (uppercase in Fig. 1A)
the plasmid pG3SVL-A (Takagaki et al. 1988) was digested with
MfeI and HpaI, treated with calf intestinal phosphatase, then
ligated to the preformed oligonucleotide duplex 5pAACAA
CATATG/5pAATTCATATGTTGTT. After sequencing and large-
scale preparation, the resulting plasmid pSVUP was sequentially
digested with NdeI and mung bean nuclease (NEB), then gel pu-
rified on 0.9% agarose to yield a blunt-ended SP6 RNA polymerase
transcription template whose transcript terminates exactly at the
wild-type poly(A) site. The AAUAAA poly(A) site mutant version,
pmutSVUP, was made analogously starting from a site-specific
mutant version of pG3SVL-A containing the U→A mutation.
Trace labeling with [-32P]UTP during a large-scale transcription
reaction including the cap analog (NEB) allowed for quantitation
of the gel-purified product. The downstream piece was synthesized
by Dharmacon and deprotected according to the manufacturer’s
instructions. After purification on a 20% denaturing polyacryl-
amide gel and phosphorylation using T4 polynucleotide kinase
(NEB) and [-32P]ATP (6000 Ci/mmole), the upstream and
downstream pieces were mixed in a 1:1:1 molar ratio with the
gel-purified oligodeoxynucleotide ligation splint 5-GAATGCA
ATTGTTGTTGTTAACTTG using T4 DNA ligase (Promega, 20
U/µL). Typically, 25 pmoles of each component were ligated in a
16 µL ligation at 30°C for 4.5 h. The final product was gel purified
on 6% DPAGE and resuspended in DEPC-treated water. The uni-
formly labeled (UL), 5-capped substrate was prepared by stan-
dard run-off transcription using DraI-digested pG3SVL-A plasmid
(or U→A mutant version) as the template and either [-32P]UTP
orGTP as the internal label. This substrate is 24 nucleotides longer
at the 3end than the SSL substrate but underwent 3 cleavage in
nuclear extract no more efficiently than did a uniformly labeled
version of the SSL substrate (not shown).
UV cross-linking
Cross-linking reactions (10 µL) were assembled on ice using 5 µL
dialyzed Hela cell nuclear extract and the following components at
these final concentrations: tRNA 0.1 mg/mL; DTT 2 mM; RNA-
seIn (Promega) 0.05 U/µL; EDTA 2 mM; creatine phosphate 40
mM; RNA substrate ∼1–5 nM. The mixture was incubated at 30°C
for 30 min then transferred to a microwell mini-tray (Nalge Nunc)
that had been frozen into a tray of ice. The tray was placed 3.5
inches from the 254-nm light source of a Stratalinker UV irradia-
tor (Stratagene) and irradiated for 8 min. The contents of the wells
were transferred to a clean microfuge tube, mixed with 1 µL of
RNAse A (10 mg/mL stock solution) and incubated at 37°C for
2–4 h. For Figure 1B, lane 9, 1 µL of calf intestinal alkaline phos-
phatase (NEB, 10 U/µL) was added and the incubation continued
for 20 min. Cross-linking with the UL substrate was done identi-
cally. Due to the greater number of radioactive phosphates in the
UL substrate, the gels containing reactions with the two different
substrates were exposed for different times and the images aligned
in the Figure to reproduce the original gel.
Immunoprecipitations
The crude cross-linked reaction was diluted with 140 µL of IP2,
precleared with rocking at 4°C from 4–14 h, and then transferred
to 12 µL (washed and drained) of IP beads for the same amount
of time. For those samples where the reaction was heat denatured
before the immunoprecipitation, the crude reaction was diluted
with 140 µL of IP2 and boiled for 4 min. The mixture was allowed
to cool to room temperature and spun in a microfuge to clarify.
The IP beads consisted of protein A–sepharose (CL-4B, Pharma-
cia) with (for -Cstf-64 3A7 and -CTD 8WG16 mouse mAbs) or
without (for polyclonal antibodies) prebinding a rabbit anti-
mouse IgG Fc fragment-specific antibody (Jackson ImmunoRe-
search). After the immunoprecipitation, the beads were washed
with IP2 (3 × 500 µL), 1 × PBS (1 × 500 µL) and finally with IP2
without BSA or NP-40 (1 × 500 µL). The washed beads were
boiled for 4 min in 20 µL of 3× SDS loading buffer and the entire
mixture was loaded onto an 8% SDS polyacrylamide gel. The gel
was fixed and stained with coomassie before drying on paper and
exposure to either Kodak X-ray film or a phosphorImager screen.
In vitro pre-mRNA 3 processing reactions
In vitro cleavage reactions were assembled on ice and contained
6.25 µL of the Hela cell nuclear extract described above per 12.5 µL
of reaction volume. In addition to the extract buffer components
the following were included at these final concentrations unless
otherwise indicated. For the experiment shown in Figure 3A,
tRNA 0.1 mg/mL; DTT 2 mM; RNAseIn (Promega) 0.056 U;
creatine phosphate 40 mM; polyvinyl alcohol (PVA) 2.5%; SV40
L/ Dra I 5capped, uniformly labeled with [-32P]GTP or UTP
RNA substrate 1–5 nM. Zinc chloride, EDTA, and 2-dATP (but
not ATP) were also added as indicated. In the reactions shown in
Figure 3B,C, the metal chelators were incubated with the nuclear
extract (nondialyzed) for 5 min at 30°C before replacing on ice
and adding the substrate and other components. All cleavage re-
actions proceeded for 2 h at 30°C and were then stopped by
treatment with proteinase K, phenol:chloroform extraction, and
ethanol precipitation. Products were resolved on a 6% denaturing
sequencing gel, dried, and exposed to either Kodak film or a phos-
phorImager screen. The zinc-specific chelators TPEN and OP were
purchased from Fluka.
Yeast methods
We constructed a Saccharomyces cerevisiae strain (OCY1) with a
chromosomal deletion of the YSH1 gene (ysh1HIS3), containing
CPSF-73 as the mRNA 3 endonuclease
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wild-type YSH1 on the URA3 plasmid pMGL4. Plasmid shuffling
was performed by transforming OCY1 strain with a LEU2 plasmid,
pMGL3, containing either wild-type YSH1, mutant ysh1-E209Q or
any gene, and subsequently counterselecting the URA3 marker on
SC plates lacking leucine and histidine and containing 5-FOA.
Mutant alleles of YSH1 were created by oligonucleotide-directed
mutagenesis using the QuikChange Site-Directed Mutagenesis Kit
(Stratagene) according to the manufacturer’s instructions. The
yeast strains were transformed by the lithium acetate technique
(Gietz and Schiestl 1991), and plasmids were maintained by
growth in selective medium. Media preparation, tetrad dissection,
genomic DNA isolation, plasmid shuffling, and all other yeast
manipulations were performed by standard methods (Ausubel et
al. 1991; Guthrie and Fink 1991). All the S. cerevisiae yeast strains
used were isogenic derivatives of W303. OCY1 (MATa/MAT
ura3-52/ ura3-52 trp1-1/ trp1-1 ade2-1/ ade2-1 leu2-3,112/ leu2-
3,112, his3-11,15/ his3-11,15 ade2-1/ ade2-1 YSH1/ysh1HIS
[pMGL4-YSH1]); OCY2 (MATa ura3-52 trp1-1 ade2-1 leu2-3,112,
his3-11,15 ade2-1 YSH1/ysh1HIS3 [pMGL4-YSH1]); OCY3
(MATa ura3-52 trp1-1 ade2-1 leu2-3,112, his3-11,15 ade2-1 YSH1/
ysh1HIS3; [pMGL4-YSH1, pMGL3-YSH1]); OCY4 (MATa
ura3-52 trp1-1 ade2-1 leu2-3,112, his3-11,15 ade2-1 YSH1/
ysh1HIS3 [pMGL4-YSH1, pMGL3-ysh1-209]); OCY5 (MATa
ura3-52 trp1-1 ade2-1 leu2-3,112, his3-11,15 ade2-1 YSH1/
ysh1HIS3 [pMGL4-YSH1, pMGL3]).
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